請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9931
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴美淑(Mei-Shu, Lai) | |
dc.contributor.author | Chi-Te Wang | en |
dc.contributor.author | 王棨德 | zh_TW |
dc.date.accessioned | 2021-05-20T20:50:11Z | - |
dc.date.available | 2008-08-13 | |
dc.date.available | 2021-05-20T20:50:11Z | - |
dc.date.copyright | 2008-08-13 | |
dc.date.issued | 2008 | |
dc.date.submitted | 2008-06-14 | |
dc.identifier.citation | Baloh, R.W., Yue, Q., Furman, J. M., Nelson, S.F. (1997). Familial episodic ataxia: clinical heterogeneity in four families linked to chromosome 19p. Ann Neurol 41: 8-16.
Basser, L. S. (1964). Benign paroxysmal vertigo of childhood. (a variety of Vestibular neuronitis). Brain, 87, 141-52. Bickerstaff, E.R. (1961) Basilar artery migraine. Lancet 1: 15-7. Bikhazi, P., Jackson, C., Ruckenstein, M. J. (1997). Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 18: 350-4. Brantberg, K., Trees, N., Baloh, R.W. (2005). Migraine-associated vertigo. Acta Otolaryngol 125: 276-9. Cass, S. P., Furman, J. M., Ankerstjerne, K., Balaban, C., Yetiser, S. Aydogan, B. (1997). Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 106: 182-9. Cutrer, F. M., Baloh, R. W. (1992). Migraine-associated dizziness. Headache 32: 300-4. Dieterich, M., Brandt, T. (1999). Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol 246: 883-92. Evers, S., Afra, J., Frese, A., Goadsby, P. J., Linde, M., May, A., Sandor, P. S. (2006). EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol 13: 560-72. Furman, J. M., Marcus, D. A., Balaban, C. D. (2003). Migrainous vertigo: development of a pathogenetic model and structured diagnostic interview. Curr Opin Neurol 16: 5-13. Goadsby, P. J., Lipton, R. B., Ferrari, M. D. (2002). Migraine--current understanding and treatment. N Engl J Med 346: 257-70. Harker, L. A., Rassekh, C. H. (1987). Episodic vertigo in basilar artery migraine. Otolaryngol Head Neck Surg 96: 239-50. Johnson, G. D. (1998). Medical management of migraine-related dizziness and vertigo. Laryngoscope 108: 1-28. Kayan, A., Hood, J. D. (1984). Neuro-otological manifestations of migraine. Brain 107: 1123-42. Kuritzky, A., D., Ziegler, K. Hassanein, R. (1981). Vertigo, motion sickness and migraine. Headache 21: 227-31. Lempert, T., Neuhauser, H. (2005). Migrainous vertigo. Neurol Clin 23(3): 715-30. Liao, L. J., Young, Y. H. (2004). Vestibular evoked myogenic potentials in basilar artery migraine. Laryngoscope 114: 1305-9. Maione, A. (2006). Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 116: 1782-6. MacGregor, A. (2000). Migraine associated with menstruation. Funct Neurol 15 (Suppl 3): 143-53. Neuhauser, H., Leopold, M., von Brevern, M., Arnold G., Lempert, T. (2001). The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 56: 436-41. Neuhauser, H. K., Radtke, A., von Brevern, M., Feldmann, M., Lezius, F., Ziese, T., Lempert, T. (2006). Migrainous vertigo: prevalence and impact on quality of life. Neurology 67: 1028-33. Oh, A. K., Lee, H., Jen, J. C., Corona, S., Jacobson, K. M., Baloh, R. W. (2001). Familial benign recurrent vertigo. Am J Med Genet 100: 287-91. Olsson, J. E. (1991). Neurotologic findings in basilar migraine. Laryngoscope 101 (Suppl 52): 1-41. Recober, A., Geweke, L. O. (2005). Menstrual migraine. Curr Neurol Neurosci Rep 5: 93-8. Reploeg, M. D., Goebel, J. A. (2002). Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 23: 364-71. Savundra, P. A., Carroll, J. D.,Davies, R. A., Luxon, L. M. (1997). Migraine-associated vertigo. Cephalalgia 17: 505-10 Silberstein, S. D. (2000). Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55: 754-62. Slater, R. (1979). Benign recurrent vertigo. J Neurol Neurosurg Psychiatry 42: 363-7. Sturzenegger, M. H. Meienberg, O. (1985). Basilar artery migraine: a follow-up study of 82 cases. Headache 25: 408-15. The International Classification of Headache Disorders, 2nd Edition (2004), Cephalalgia 24 (suppl 1): 1-160 von Brevern, M., Zeise, D., Neuhauser, H., Clarke, A. H., Lempert, T. (2005). Acute migrainous vertigo: clinical and oculographic findings. Brain 128: 365-74. Wang, S. J., Fuh, J. L.,Young, Y. H.,Lu, S. R., Shia, B. C. (2000). Prevalence of migraine in Taipei, Taiwan: a population-based survey. Cephalalgia 20: 566-72. Watson, P., Steele, J. C. (1974). Paroxysmal dyseguilibrium in the migraine syndrome of childhood. Arch Otolaryngol 99: 177-9. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/9931 | - |
dc.description.abstract | 目的 本研究之主要目的為分析與偏頭痛相關之眩暈及頭暈患者之臨床表現,並尋找與治療效果相關之因子。此外,一併探討不同診斷疾病群間之關係。
方法 病患來源為自2007年7月至2008年1月於耳鼻喉科眩暈特別門診就診之病患,所有病患均接受一系列之檢查並排除其他可能之診斷。研究之收案條件為5次以上之偏頭痛與2次以上之前庭症狀,計110名病患納入本研究。每位患者都接受制式化的當面訪談,並收集相關之臨床症狀與檢查結果,再依據基底型偏頭痛 ( BtM)、確定偏頭痛型眩暈 (dMV)、與疑似偏頭痛型眩暈(pMV) 之診斷基準進行分類比較。除了7名患者未完成治療與追蹤外,其他病人均接受藥物治療為期三個月,結束後依病歷記載分析其治療結果。 結果 病患之平均年齡為40歲,多數為女性(85%)且有偏頭痛之家族史(72%),症狀發作之年齡大多介於20至 29歲之間,且61%之患者以頭痛為初始表現。106位(96%)患者均表示有一種以上之偏頭痛誘發因子。與治療結果相關之因子為年齡 (年齡每小10歲之危險性為2.38倍,95%信賴區間: 1.39 ~ 4.07),前庭症狀之發作頻率 (危險性=7.73, 95%信賴區間:2.05 ~ 19.1),以及異常的視運動眼振測驗 (危險性=5.40, 95%信賴區間: 1.60 ~ 18.2)。此外,BtM 與 dMV兩組之臨床表現相似,包括偏頭痛之相關症狀、動暈症、以及頭痛與頭暈間之時序性,但BtM 組有較多神經學症狀與較頻繁之發作頻率,且眼振電圖檢查出現較多中樞性徵象。反之,pMV組則屬病症最輕微。 結論 本研究收集了與偏頭痛相關之眩暈及頭暈在台灣地區之代表性族群,且臨床表現與文獻之記載相符。與治療結果相關之重要因子包括年齡、前庭症狀之發作頻率與異常之視運動眼振測驗。三組不同診斷疾病群之間的關係可能意味此一症候群在臨床嚴重度的不同,其中基底型偏頭痛之症狀最為嚴重且治療成果最不理想。 | zh_TW |
dc.description.abstract | Objective This study was designed to analyze the clinical manifestation of patients with migraine-related vertigo and dizziness, and explore the association between clinical characteristics and treatment effectiveness. The relationships between different diagnostic groups were investigated as well.
Method The source population was comprised of patients visiting a vertigo special clinic from July 2007 to January 2008. Subjects with other potential diagnoses were excluded. Inclusion criteria consisted of > 5times of migrainous headache and > 2 times of vertigo/dizziness episodes. One-hundred and ten subjects were enrolled and eligible for this study. All the patients received structured interview of clinical presentations, and the results of audiovestibular function tests were recorded. Further classification of study subjects were based on the diagnostic criteria of basilar type migraine (BtM), definite migrainous vertigo (dMV) and probable migrainous vertigo (pMV). Excluding 7 subjects lost from clinic, treatment effectiveness was evaluated in 103 subjects after a consecutive 3-month medication. Result The demographic characteristics constitute a mean age of 40 years old, female predominance (85%), strong family preponderance (72%), plateau of onset of symptoms around 20-29 years old, and headache as the first presenting symptom in 61% of subjects. Migraine precipitants were identified in 106 subjects (96%). Significant factors associated with poor response are: younger age at presentation (adjusted odds ratio (aOR) =2.38 for each 10-year decline, 95% confidence interval (CI): 1.39 ~ 4.07), frequent vestibular episodes (aOR=7.73, 95% CI: 2.05 ~ 19.1), and abnormal optokinetic nystagmus (OKN) tests (aOR=5.40, 95% CI: 1.60 ~ 18.2). Food precipitation showed borderline correlation with treatment response (aOR=0.31, 95% CI: 0.09 ~ 1.04). Furthermore, BtM and dMV group are similar in clinical presentation, e.g. migrainous symptoms, motion sickness and sequential relationship between migraine and vertigo, but differs in that BtM had more extensive neurological symptoms, more frequent vestibular symptoms, more central signs on electronystagmography tests, and also, the worst treatment effectiveness. In contrast, pMV group represents the least severe clinical manifestation. Conclusion This study enrolled a representative sample of migraine-related vertigo and dizziness in Taiwan. The significant factors in relation to treatment effectiveness are identified, i.e. frequency of vestibular episodes, age at presentation, and OKN abnormalities. The relationship between these three diagnostic groups is most likely a distribution of severity across the disease spectrum, with BtM presenting the most extensive involvement of the brainstem and the worst treatment response. | en |
dc.description.provenance | Made available in DSpace on 2021-05-20T20:50:11Z (GMT). No. of bitstreams: 1 ntu-97-R95846005-1.pdf: 545152 bytes, checksum: 372ef49d9b9c91722a2f67fe30ed902c (MD5) Previous issue date: 2008 | en |
dc.description.tableofcontents | Table of Contents
口試委員會審定書……………………………………………i Abstract…………………………………………………….. ii 中文摘要………………………………………………………..iv 1. Introduction……………………………………….. ….1 2. Literature review…………………………………………3 2.1 Clinical presentation ………………………………..3 2.2 Objective assessment ………………………………...6 2.3 Pathophysiology………………………………………...8 2.4 Nomenclature and diagnostic criteria…………….10 2.5 Therapeutic options and studies of treatment effectiveness......................................12 3. Objectives…………………………………………………15 4. Subjects and Methods………………………………………………………….17 4.1 Study design and enrollment of subjects………..17 4.2 Data collection and definition of variables……20 4.3 Audiovestibular function test………………………22 4.4 Diagnostic and classification criteria………..24 4.5 Result analysis and statistical methods…………26 5. Results……………………………………………………28 5.1 Descriptive analysis of clinical manifestation…28 5.1.1 Demographics…………………………............…28 5.1.2 Characteristics of vestibular symptoms…………30 5.1.3 Characteristics of migrainous headache……….32 5.1.4 Audiovestibular function results…………………34 5.2 Correlation between clinical manifestation and treatment effectiveness…...........................35 5.2.1 Univariate analysis…………………………..…….36 5.2.2 Multivariate analysis……………..……….……..42 5.3 Comparison between different diagnostic groups…45 5.3.1 Demographics …………………………………………45 5.3.2 Characteristics of vestibular symptoms………46 5.3.3 Characteristics of migrainous headache ….……48 5.3.4 Audiovestibular function results…………………51 5.3.5 Multivariate analysis of differentiating factors …………………......................................52 5.3.6 Treatment effectiveness of three diagnostic groups………………..................................53 6. Discussion…………………………………………………54 6.1 Study population…………………………………………54 6.2 Clinical manifestation of enrolled subjects……55 6.3 Treatment effectiveness and its correlation with clinical manifestations.............................57 6.4 Relationship between different diagnostic groups61 6.5 Limitations……………………………….…………....67 7. Conclusion …………………………………………………69 8. Perspectives………………………………………………..70 9. References……………………………………………………71 10. Appendix Appendix I. Summary of diagnostic criteria………………75 Appendix II. Protocol of structured interview…………76 Appendix III. Informed consent………………………………77 Appendix IV. Food precipitation inquiry………78 | |
dc.language.iso | en | |
dc.title | 從臨床流行病學與神經耳科學來探討與偏頭痛相關之眩暈及頭暈 | zh_TW |
dc.title | Clinical Epidemiological and Neurotological Approaches to Migraine-related Vertigo and Dizziness | en |
dc.type | Thesis | |
dc.date.schoolyear | 96-2 | |
dc.description.degree | 碩士 | |
dc.contributor.coadvisor | 楊怡和(Yi-Ho, Young) | |
dc.contributor.oralexamcommittee | 杜永光,蕭朱杏,鄭博文 | |
dc.subject.keyword | 偏頭痛,眩暈,頭暈,治療,視運動眼振, | zh_TW |
dc.subject.keyword | migraine,vertigo,dizziness,treatment,optokinetic nystagmus, | en |
dc.relation.page | 78 | |
dc.rights.note | 同意授權(全球公開) | |
dc.date.accepted | 2008-06-15 | |
dc.contributor.author-college | 公共衛生學院 | zh_TW |
dc.contributor.author-dept | 預防醫學研究所 | zh_TW |
顯示於系所單位: | 流行病學與預防醫學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-97-1.pdf | 532.38 kB | Adobe PDF | 檢視/開啟 |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。